1. AB0086 PTH Stimulates Cartilage Formation in Low Turnover Patients – a Possible Systemic Anabolic Treatment for OA?. (9th June 2015) Authors: Siebuhr, A.S.; Gudmann, N.S.; Musa, K.; Kehlet, S.; Hansen, G.; Byrjalsen, I.; Andersen, J.; Bihlet, A.; Christiansen, C.; Karsdal, M.A.; Bay-Jensen, A.-C.; Henriksen, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0174 Changes in Type VI Collagen Degradation Reflect Response To Treatment in Rheumatoid Arthritis Patients Treated with Tocilizumab. (15th July 2016) Authors: Thudium, C.S.; Gudmann, N.S.; Musa, K.; Karsdal, M.A.; Bay-Jensen, A.-C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0839 Identification of a Inflammatory Phenotype with Higher Likelihood of Progression in OA: Analysis of Womac Pain Sub-Questions, C3M and U-CTX-II from Two Phase 3 Randomized Clinical Trials with Treatment of Symptomatic Knee Osteoarthritis. (9th June 2015) Authors: Bay-Jensen, A.C.; Byrjalsen, I.; Musa, K.; Bihlet, A.; Alexandersen, P.; Andersen, J.R.; Riis, B.J.; Christiansen, C.; Karsdal, M.A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of an inflammatory phenotype with higher likelihood of progression in OA: Analysis of womac pain sub-questions, C3M and U-CTX-II from two phase 3 randomized clinical trials with treatment of symptomatic knee osteoarthritis. (April 2015) Authors: Bay-Jensen, A.C.; Byrjalsen, I.; Musa, K.; Bihlet, A.; Alexandersen, P.; Andersen, J.R.; Riis, B.J.; Christiansen, C.; Karsdal, M.A. Journal: Osteoarthritis and cartilage Issue: Volume 23(2015)Supplement 2 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0045 The Activation of the Synovial Membrane Results in Release of Tissue Specific Biomarkers, Which in Turn can Act as Soluble Disease Activity Measures in Rheumatoid Arthritis. (9th June 2015) Authors: Kjelgaard-Petersen, C.F.; Siebuhr, A.S.; Byrjalsen, I.; Musa, K.; Christiansen, T.; Karsdal, M.A.; Bay-Jensen, A.C. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0101 Tissue metabolite of type i collagen, c1m, and crp predicts structural progression of rheumatoid arthritis. (12th June 2018) Authors: Bay-Jensen, A.C.; Platt, A.; Jenkins, M.; Weinblatt, M.; Byrjalsen, I.; Musa, K.; Genovese, M.C.; Karsdal, M.A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0453 Biomarkers of Bone and Cartilage Remodeling in OA is Strongly Associated with Pain and Obesity: Data from Two Phase 3 Randomized Clinical Trials in Symptomatic Knee OA. (9th June 2015) Authors: Bihlet, A.R.; Bay-Jensen, A.-C.; Karsdal, M.A.; Byrjalsen, I.; Riis, B.J.; Christiansen, C.; Andersen, J.R.; Musa, K.; Alexandersen, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗